Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351


Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.

Hannan EL, Zhong Y, Ling FSK, Tamis-Holland J, Berger PB, Jacobs AK, Walford G, Venditti FJ, King SB 3rd.

Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526. [Epub ahead of print]


Sex differences in the treatment and outcomes of patients hospitalized with ST-elevation myocardial infarction.

Hannan EL, Wu Y, Tamis-Holland J, Jacobs AK, Berger PB, Ling FSK, Walford G, Venditti FJ, King SB 3rd.

Catheter Cardiovasc Interv. 2019 Apr 22. doi: 10.1002/ccd.28286. [Epub ahead of print]


Treatment of Coronary Artery Disease and Acute Myocardial Infarction in Hospitals With and Without On-Site Coronary Artery Bypass Graft Surgery.

Hannan EL, Zhong Y, Wu Y, Berger PB, Jacobs AK, Walford G, Venditti FJ, Ling FSK, Tamis-Holland J, King SB 3rd.

Circ Cardiovasc Interv. 2019 Jan;12(1):e007097. doi: 10.1161/CIRCINTERVENTIONS.118.007097.


Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock.

Kochar A, Al-Khalidi HR, Hansen SM, Shavadia JS, Roettig ML, Fordyce CB, Doerfler S, Gersh BJ, Henry TD, Berger PB, Jollis JG, Granger CB.

JACC Cardiovasc Interv. 2018 Sep 24;11(18):1824-1833. doi: 10.1016/j.jcin.2018.06.030.


Plasma Ceramides.

Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB, Jaffe AS.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1933-1939. doi: 10.1161/ATVBAHA.118.311199.


2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings.

Hannan EL, Samadashvili Z, Cozzens K, Berger PB, Chikwe J, Jacobs AK, Walford G, Ling FSK, Venditti FJ, Gold J, King SB 3rd.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):473-478. doi: 10.1016/j.jcin.2018.01.235.


Association of Coronary Vessel Characteristics With Outcome in Patients With Percutaneous Coronary Interventions With Incomplete Revascularization.

Hannan EL, Zhong Y, Berger PB, Jacobs AK, Walford G, Ling FSK, Venditti FJ, King SB 3rd.

JAMA Cardiol. 2018 Feb 1;3(2):123-130. doi: 10.1001/jamacardio.2017.4787.


Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.

Jollis JG, Al-Khalidi HR, Roettig ML, Berger PB, Corbett CC, Doerfler SM, Fordyce CB, Henry TD, Hollowell L, Magdon-Ismail Z, Kochar A, McCarthy JJ, Monk L, O'Brien P, Rea TD, Shavadia J, Tamis-Holland J, Wilson BH, Ziada KM, Granger CB.

Circulation. 2018 Jan 23;137(4):376-387. doi: 10.1161/CIRCULATIONAHA.117.032446. Epub 2017 Nov 14.


Impact of Regional Systems of Care on Disparities in Care Among Female and Black Patients Presenting With ST-Segment-Elevation Myocardial Infarction.

Hinohara TT, Al-Khalidi HR, Fordyce CB, Gu X, Sherwood MW, Roettig ML, Corbett CC, Monk L, Tamis-Holland JE, Berger PB, Burchenal JEB, Wilson BH, Jollis JG, Granger CB.

J Am Heart Assoc. 2017 Oct 24;6(10). pii: e007122. doi: 10.1161/JAHA.117.007122.


Temporal Trends in the Incidence, Prevalence, and Survival of Patients With Atrial Fibrillation From 2004 to 2016.

Williams BA, Honushefsky AM, Berger PB.

Am J Cardiol. 2017 Dec 1;120(11):1961-1965. doi: 10.1016/j.amjcard.2017.08.014. Epub 2017 Aug 30.


Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.

Williams BA, Evans MA, Honushefsky AM, Berger PB.

J Am Heart Assoc. 2017 Oct 12;6(10). pii: e006669. doi: 10.1161/JAHA.117.006669.


Is 30-Day Mortality after Admission for Heart Failure an Appropriate Metric for Quality?

Faillace RT, Yost GW, Chugh Y, Adams J, Verma BR, Said Z, Sayed II, Honushefsky A, Doddamani S, Berger PB.

Am J Med. 2018 Feb;131(2):201.e9-201.e15. doi: 10.1016/j.amjmed.2017.09.007. Epub 2017 Sep 21.


Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics.

Hannan EL, Zhong Y, Jacobs AK, Ling FSK, Berger PB, Walford G, Venditti FJ, King SB 3rd.

Am Heart J. 2017 Apr;186:118-126. doi: 10.1016/j.ahj.2017.01.015. Epub 2017 Feb 8.


Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib Treatment.

Parra-Guillen ZP, Berger PB, Haschke M, Donzelli M, Winogradova D, Pfister B, Früh M, Gillessen S, Krähenbühl S, Kloft C, Joerger M.

Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):309-315. doi: 10.1111/bcpt.12801. Epub 2017 Jun 19.


Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.

Hannan EL, Samadashvili Z, Cozzens K, Gesten F, Osinaga A, Fish DG, Donahue CL, Bass RJ, Walford G, Jacobs AK, Venditti FJ, Stamato NJ, Berger PB, Sharma S, King SB 3rd.

J Am Coll Cardiol. 2017 Mar 14;69(10):1234-1242. doi: 10.1016/j.jacc.2016.12.025.


Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.

Ko D, Thigpen JL, Otis JA, Forster K, Henault L, Quinn E, Tripodis Y, Berger PB, Limdi N, Hylek EM.

Int J Cardiol. 2017 Jan 15;227:808-812. doi: 10.1016/j.ijcard.2016.10.055. Epub 2016 Oct 24.


STEMI Care in Poland and the United States: Both Have Some Distance Yet to Travel.

Berger PB, Perini M, Becker LB.

JACC Cardiovasc Interv. 2017 Mar 13;10(5):448-450. doi: 10.1016/j.jcin.2017.01.006. Epub 2017 Feb 15. No abstract available.


The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public Reporting.

Hannan EL, Zhong Y, Cozzens K, Gesten F, Friedrich M, Berger PB, Jacobs AK, Walford G, Ling FS, Venditti FJ, King SB 3rd.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):224-231. doi: 10.1016/j.jcin.2016.10.040.


Association of Rapid Care Process Implementation on Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction Networks.

Fordyce CB, Al-Khalidi HR, Jollis JG, Roettig ML, Gu J, Bagai A, Berger PB, Corbett CC, Dauerman HL, Fox K, Garvey JL, Henry TD, Rokos IC, Sherwood MW, Wilson BH, Granger CB; STEMI Systems Accelerator Project.

Circ Cardiovasc Interv. 2017 Jan;10(1). pii: e004061. doi: 10.1161/CIRCINTERVENTIONS.116.004061.


Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator.

Jollis JG, Al-Khalidi HR, Roettig ML, Berger PB, Corbett CC, Dauerman HL, Fordyce CB, Fox K, Garvey JL, Gregory T, Henry TD, Rokos IC, Sherwood MW, Suter RE, Wilson BH, Granger CB; Mission: Lifeline STEMI Systems Accelerator Project.

Circulation. 2016 Aug 2;134(5):365-74. doi: 10.1161/CIRCULATIONAHA.115.019474.


Understanding the Adverse Effects of Ticagrelor in Practice.

Granger CB, Berger PB.

JAMA Cardiol. 2016 Jul 1;1(4). doi: 10.1001/jamacardio.2016.1018. No abstract available.


Cyclosporine for Reperfusion Injury After Cardiac Arrest: Too Little Too Late?

Becker LB, Berger PB.

JAMA Cardiol. 2016 Aug 1;1(5):566-7. doi: 10.1001/jamacardio.2016.1822. No abstract available.


Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.

Rafique AM, Nayyar P, Wang TY, Mehran R, Baber U, Berger PB, Tobis J, Currier J, Dave RH, Henry TD.

JACC Cardiovasc Interv. 2016 May 23;9(10):1036-46. doi: 10.1016/j.jcin.2016.02.013.


Disparities in the Use of Drug-Eluting Coronary Stents by Race, Ethnicity, Payer, and Hospital.

Hannan EL, Racz MJ, Walford G, Jacobs AK, Stamato NJ, Gesten F, Berger PB, Sharma S, King SB 3rd.

Can J Cardiol. 2016 Aug;32(8):987.e25-31. doi: 10.1016/j.cjca.2016.01.012. Epub 2016 Jan 22.


Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Interventions: Characteristics, Success, and Outcomes.

Hannan EL, Zhong Y, Jacobs AK, Stamato NJ, Berger PB, Walford G, Sharma S, Venditti FJ, King SB 3rd.

Circ Cardiovasc Interv. 2016 May;9(5):e003586. doi: 10.1161/CIRCINTERVENTIONS.116.003586.


Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.

Kahlon TS, Barn K, Akram MM, Blankenship JC, Bower-Stout C, Carey DJ, Sun H, Tompkins Weber K, Skelding KA, Scott TD, Green SM, Berger PB.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):245-251. doi: 10.1002/ccd.26567. Epub 2016 May 3.


Appending Limited Clinical Data to an Administrative Database for Acute Myocardial Infarction Patients: The Impact on the Assessment of Hospital Quality.

Hannan EL, Samadashvili Z, Cozzens K, Jacobs AK, Venditti FJ, Holmes DR Jr, Berger PB, Stamato NJ, Hughes S, Walford G.

Med Care. 2016 May;54(5):538-45. doi: 10.1097/MLR.0000000000000520.


Response to a Differing Perspective: The Real Issues Related to Public Reporting Around Percutaneous Coronary Intervention.

Berger PB.

JACC Cardiovasc Interv. 2016 Mar 14;9(5):513-5. doi: 10.1016/j.jcin.2016.01.026. No abstract available.


Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.

Reed GW, Cannon CP, Waalen J, Teirstein PS, Tanguay JF, Berger PB, Angiolillo DJ, Price MJ.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):190-198. doi: 10.1002/ccd.26428. Epub 2016 Feb 23.


Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?

Sibbing D, Kastrati A, Berger PB.

Eur Heart J. 2016 Apr 21;37(16):1284-95. doi: 10.1093/eurheartj/ehv717. Epub 2015 Dec 27. Review.


Paroxysmal atrial fibrillation and the hazards of under-treatment.

Aronis KN, Thigpen JL, Tripodis Y, Dillon C, Forster K, Henault L, Quinn EK, Berger PB, Limdi NA, Hylek EM.

Int J Cardiol. 2016 Jan 1;202:214-20. doi: 10.1016/j.ijcard.2015.09.006. Epub 2015 Sep 11.


Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States.

Wang TY, Henry TD, McCoy LA, Berger PB, Cohen DJ, Effron MB, Zettler M, Baker BA, Messenger JC, Peterson ED.

Am Heart J. 2015 Oct;170(4):706-14. doi: 10.1016/j.ahj.2015.06.021. Epub 2015 Jul 2.


Impact of Switching From Prasugrel to Clopidogrel Shortly After a Percutaneous Coronary Intervention Without a Loading Dose of Clopidogrel.

Mizrahi E, Suryadevara RS, Barn K, Boga G, Akram MM, Ismail-Sayed I, Henry YM, Troup MA, Berger PB.

J Invasive Cardiol. 2015 Dec;27(12):543-6. Epub 2015 Sep 15.


Finding the Proper Context for the MATRIX Trial.

Berger PB.

N Engl J Med. 2015 Sep 10;373(11):1069-70. doi: 10.1056/NEJMe1509637. Epub 2015 Sep 1. No abstract available.


Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study.

Wang TY, Henry TD, Effron MB, Honeycutt E, Hess CN, Zettler ME, Cohen DJ, Baker BA, Berger PB, Anstrom KJ, Angiolillo DJ, Peterson ED; TRANSLATE-POPS Investigators.

Circ Cardiovasc Interv. 2015 Jun;8(6):e001712. doi: 10.1161/CIRCINTERVENTIONS.114.001712.


Does Preoperative Platelet Function Predict Bleeding in Patients Undergoing Off Pump Coronary Artery Bypass Surgery?

Berger PB, Kirchner HL, Wagner ES, Ismail-Sayed I, Yahya S, Benoit C, Blankenship JC, Carter R, Casale AS, Green SM, Scott TD, Skelding KA, Woods E, Henry YM.

J Interv Cardiol. 2015 Jun;28(3):223-32. doi: 10.1111/joic.12200. Epub 2015 May 20.


Reply: Is CABG Superior to DES for Repeat Revascularization in Patients With Isolated Proximal LAD Disease?

Hannan EL, Zhong Y, Walford G, Holmes DR Jr, Venditti FJ, Berger PB, Jacobs AK, Stamato NJ, Curtis JP, Sharma S, King SB 3rd.

J Am Coll Cardiol. 2015 Apr 28;65(16):1716. doi: 10.1016/j.jacc.2015.02.030. No abstract available.


Assessing hospital performance for acute myocardial infarction: how should emergency department transfers be attributed.

Samadashvili Z, Hannan EL, Cozzens K, Walford G, Jacobs AK, Berger PB, Holmes DR Jr, Venditti FJ, Curtis J.

Med Care. 2015 Mar;53(3):245-52. doi: 10.1097/MLR.0000000000000305.


Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation.

Thigpen JL, Dillon C, Forster KB, Henault L, Quinn EK, Tripodis Y, Berger PB, Hylek EM, Limdi NA.

Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):8-14. doi: 10.1161/CIRCOUTCOMES.113.000371. Epub 2015 Jan 13.


Should proton pump inhibitors be withheld from patients taking clopidogrel? The issue that has been giving me heartburn!

Berger PB.

Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):6-7. doi: 10.1161/CIRCOUTCOMES.114.001586. Epub 2015 Jan 13. No abstract available.


Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease.

Hannan EL, Zhong Y, Walford G, Holmes DR Jr, Venditti FJ, Berger PB, Jacobs AK, Stamato NJ, Curtis JP, Sharma S, King SB 3rd.

J Am Coll Cardiol. 2014 Dec 30;64(25):2717-26. doi: 10.1016/j.jacc.2014.09.074.


A radial resolution to a warfarin worry.

Blankenship JC, Berger PB.

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):89-90. doi: 10.1002/ccd.25745. No abstract available.


Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin.

Baker NC, O'Connell EW, Htun WW, Sun H, Green SM, Skelding KA, Blankenship JC, Scott TD, Berger PB.

Am Heart J. 2014 Oct;168(4):537-44. doi: 10.1016/j.ahj.2014.06.016. Epub 2014 Jul 3.


Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: a meta-analysis of randomised trials.

Cassese S, Byrne RA, Laugwitz KL, Schunkert H, Berger PB, Kastrati A.

EuroIntervention. 2015 Jun;11(2):196-203. doi: 10.4244/EIJY14M08_01.


Open letter for the people in Gaza--more than a military conflict.

Stall NM, Berger PB, Ray JG, Bogler T, Bell CM.

Lancet. 2014 Aug 2;384(9941):398-9. No abstract available.


Is the heat on HEAT-PPCI appropriate?

Berger PB, Blankenship JC.

Lancet. 2014 Nov 22;384(9957):1824-1826. doi: 10.1016/S0140-6736(14)61041-2. Epub 2014 Jul 4. No abstract available.


Response to Alexander.

Rashid M, Berger PB.

CMAJ. 2014 May 13;186(8):615. doi: 10.1503/cmaj.114-0032. No abstract available.


Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).

Tsimikas S, Duff GW, Berger PB, Rogus J, Huttner K, Clopton P, Brilakis E, Kornman KS, Witztum JL.

J Am Coll Cardiol. 2014 May 6;63(17):1724-34. doi: 10.1016/j.jacc.2013.12.030. Epub 2014 Feb 12.


Utilization of radial artery access for percutaneous coronary intervention for ST-segment elevation myocardial infarction in New York.

Hannan EL, Farrell LS, Walford G, Berger PB, Stamato NJ, Venditti FJ, Jacobs AK, Holmes DR Jr, Sharma S, King SB 3rd.

JACC Cardiovasc Interv. 2014 Mar;7(3):276-83. doi: 10.1016/j.jcin.2013.10.020. Epub 2014 Feb 13.


Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age.

Hannan EL, Zhong Y, Berger PB, Walford G, Curtis JP, Wu C, Venditti FJ, Higgins RS, Smith CR, Lahey SJ, King SB 3rd.

Am J Cardiol. 2014 Mar 1;113(5):803-8. doi: 10.1016/j.amjcard.2013.11.035. Epub 2013 Dec 12.


Supplemental Content

Loading ...
Support Center